{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:39:55Z","timestamp":1792226395192,"version":"4.4.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12 HS026385"],"award-info":[{"award-number":["K12 HS026385"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-023-02681-8","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T03:28:56Z","timestamp":1690514936000},"page":"2927-2930","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of a patient education platform for seborrheic dermatitis"],"prefix":"10.1007","volume":"315","author":[{"given":"Sheiva","family":"Fakhraie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Chovatiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"2681_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1468-3083.2004.00693.x","volume":"18","author":"AK Gupta","year":"2004","unstructured":"Gupta AK, Bluhm R (2004) Seborrheic dermatitis. J Eur Acad Dermatol Venereol 18:13\u201326","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2681_CR2","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.2196\/jmir.1933","volume":"15","author":"SA Moorhead","year":"2013","unstructured":"Moorhead SA, Hazlett DE, Harrison L, Carroll JK, Irwin A, Hoving C (2013) A new dimension of health care: systematic review of the uses, benefits, and limitations of social media for health communication. J Med Internet Res 15:e85","journal-title":"J Med Internet Res"},{"key":"2681_CR3","first-page":"42848","volume":"17","author":"R Chovatiya","year":"2023","unstructured":"Chovatiya R, Aldredge L, Heath C, Acevedo C, Chu DH, Hanna D, Seal M, Zirwas M (2023) Patients\u2019 and healthcare providers\u2019 perspectives on the path to diagnosis and educational resources of seborrheic dermatitis in the United States: results from a national survey. Amer Acad Dermatol Annual Meet. 17:42848","journal-title":"Amer Acad Dermatol Annual Meet."},{"key":"2681_CR4","doi-asserted-by":"publisher","DOI":"10.5070\/D3242038166","author":"RR Patel","year":"2018","unstructured":"Patel RR, Hill MK, Smith MK, Seeker P, Dellavalle RP (2018) An updated assessment of social media usage by dermatology journals and organizations. Dermatol online J. https:\/\/doi.org\/10.5070\/D3242038166","journal-title":"Dermatol online J"},{"key":"2681_CR5","first-page":"225","volume":"7","author":"R Chovatiya","year":"2023","unstructured":"Chovatiya R, Aldredge L, Heath C, Acevedo C, Chu DH, Hanna D, Seal M, Zirwas M (2023) Patient and healthcare provider perspective on the treatment patterns and patient satisfaction of seborrheic dermatitis in the united states: results from a national survey. Amer Acad Dermatol Annual Meet. 7:225","journal-title":"Amer Acad Dermatol Annual Meet."}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-023-02681-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-023-02681-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T07:02:35Z","timestamp":1698649355000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-023-02681-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":5,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2681"],"URL":"https:\/\/doi.org\/10.1007\/s00403-023-02681-8","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"assertion":[{"value":"15 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"RC has served as an advisory board member, consultant, and\/or investigator for AbbVie, Apogee, Arcutis, Argenx, ASLAN, Beiersdorf, Boehringer Ingelheim, Bristol Myers Squibb, Cara Therapeutics, Dermavant, Eli Lilly and Company, Galderma, Genentech, Incyte, LEO Pharma, L\u2019Or\u00e9al, Novan, Inc., Pfizer Inc., Regeneron, Sanofi, and UCB, and speaker for AbbVie, Arcutis, Beiersdorf, Bristol Myers Squibb, Dermavant, Eli Lilly and Company, Incyte, LEO Pharma, Novan, Inc., Pfizer Inc., Regeneron, Sanofi, and UCB. SF and TE report no conflict.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}